Swiss Global Enterprise | Cell & Gene Therapy

Starts in

June 6, 2022


Swiss Global Enterprise | Cell & Gene Therapy



In person


6 June | 2022


15:00 - 22:00





Our CEO is a panellist and will discuss the 'Common challenges in introducing Cell & Gene Therapies'

Both Switzerland and the United Kingdom are known for being industry leaders in all aspects related to Cell and Gene Therapy. It is for this reason that our Swiss delegation to the University of Cambridge aims to promote the exchange of best practices and key learnings from their respective ecosystems.

This event brings the UK- and Swiss-based ecosystems together for a joint discussion on current key topics with regards to R&D, business opportunities and future ambitions. The focus is on the current landscape of cell and gene therapy evolution in the respective countries, and how to accelerate the adoption of these therapies into health, aiming to foster Swiss and UK relations and to facilitate collaboration and interactions.

Join our CEO Dr Mark Kotter who will be part of a panel discussion 'Common challenges in introducing Cell & Gene Therapies' at 16:45. He will be joined by:

  • Dr. Stephen Ward
    Chief Manufacturing Officer at The Cell and Gene Therapy Catapult
  • Dr. Corinne Solier
    COO at Scailyte
  • Dr. George Coukos
    Director of Oncology University Hospital of Lausanne & Branch Director at Ludwig Cancer Research
  • Dr. Anna Williamson
    Executive Director, Business Development & Head of UK Business Development at Roche / Genentech